Cell Salvage
Haemonetics developed clinical autologous blood recovery over 50 years ago
Reducing the need for donated blood transfusions has well-documented benefits to the patient and cost benefits to your facility. In medium to high blood loss procedures, the Cell Saver® Elite®+ autotransfusion system provides the hospital with a fast and easy-to-use way to recover and deliver a patient’s own high-quality blood to a product bag.
Intuitive Design
The user-friendly colour touch screen is easy-to-use and large enough to be visible throughout the operating room. The integrated barcode reading technology simplifies data entry and reads the disposable sets.
Versatility
Designed for the way you work and adaptable for a wide variety of cases. From cardiac and obstetrics to orthopaedics and trauma. With flexibility to define unique settings for each group at system start-up.
Blood Quality
The Cell Saver® Elite®+ system is a critical tool in a hospital’s efforts to avoid unnecessary allogeneic transfusions while helping to reduce related costs.
Delivering Value Beyond the Technology
Investing in an autotransfusion system is an important clinical and economic decision for your hospital. With Haemonetics you have access to a comprehensive suite of programs and services to support your needs - from system implementation to education, technical support and service.
Cell Salvage Technology
Nearly every surgical procedure involves some degree of blood loss. In today's hospitals, autologous cell salvage is becoming an integral part of patient blood management protocols.
The Cell Saver® Elite®+ system provides patients with their own fresh, washed blood, helping to prevent an allogeneic transfusion along with the associated risks and costs. Its integrated SmartSuction® technology is gentle on red blood cells (RBCs), preserving them for transfusion. Its fat reduction protocol is designed for optimal performance, while still offering custom settings that allow for modifications during a procedure.
Not all products are available in all markets.